| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |